Algae cultivator Qualitas Health raises USD 10 million in funding round

By Nikita Chaurasia  Date: 2021-01-13

Algae cultivator Qualitas Health raises USD 10 million in funding round

In recent developments, privately held food and nutrition company Qualitas Health Inc. has reportedly secured USD 10 million in venture funds, as it looks to broaden the reach of its plant-based protein and omega-3 business. The company was appraised at USD 73 million during the closure of the first funding round.

The recently conducted funding round was led by renowned foodtech investor PeakBridge VC, along with other private investors including Minrav Holdings Ltd., Malta, and privately owned Mexican food service conglomerate, Arancia Group, cited sources with relevant information.

The funding round is aimed at accelerating customer acquisition as well as the commercialization of the firm’s unique plant-based protein. Moreover, Qualitas Health will utilize the funds to expand its existing clinical science channels and initiate product penetration in additional geographies.

CEO of Qualitas Health, Miguel Calatayud was reported saying that the recent investments will contribute to the company’s business expansion objective in 2021, while iwi parallelly progresses towards the industrial pilot stage of its product and conducts additional clinical studies. The company’s plant-based protein will be ready for commercialization and sale in 2022, he added.

For the record, Qualitas Health is a Texas-headquartered organization that focuses on developing pharmaceutical ingredients and high-value vegetarian food supplements. The company is best known for its algae brand, iwi, which is a direct-to-consumer manufacturer of high absorption polar lipid EPA omega 3.

Reportedly, iwi relies only on saltwater and solar energy to cleanly cultivate large amounts of Nannochrolopsis, a type of microalgae that consists of most of the essential amino acids, primarily omega 3.

With a goal of bringing sustainable and nutritious food solutions to cater to the growing population, Qualitas Health cultivates their algae in large cultivation pond systems in the deserts of Texas and New Mexico, as cited by credible sources.

Source credits -

https://www.prnewswire.com/news-releases/qualitas-healthiwi-raises-10m-in-first-close-of-new-investment-round-301205104.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Netflix confirms producing fictionalized version of Spotify’s ascension

Netflix confirms producing fictionalized version of Spotify’s ascension

By Nikita Chaurasia

Over-the-top content streaming & production giant Netflix Inc. is reportedly working on an untitled series that tells the story of one of the most successful music streaming companies, Spotify Ltd. The six-part series, already listed on Netflix,...

Edtech Byju’s is now India’s highest-valued startup at USD 16.5 billion

Edtech Byju’s is now India’s highest-valued startup at USD 16.5 billion

By Nikita Chaurasia

Byju’s, the largest education technology company, has emerged as India’s highest-valued startup after a USD 340 million funding round involving investors such as UBS Group, Blackstone, and Zoom founder Eric Yuan among others. Recently, B...

LiDAR maker Hesai Photonics secures USD 300 million in Series D funding

LiDAR maker Hesai Photonics secures USD 300 million in Series D funding

By Nikita Chaurasia

Hesai Photonics Technology Co. Ltd., a leading Shanghai-based LiDAR company, has reportedly secured USD 300 million in a Series D funding round which was led by GL Ventures LLC, Xiaomi Corporation, Hillhouse Capital Group, Meituan, and CPE. The roun...

Tesla terminates production of its Model S Plaid + variant indefinitely

Tesla terminates production of its Model S Plaid + variant indefinitely

By Nikita Chaurasia

CEO Elon Musk justified Model S Plaid as good enough against its successor. The Model S Plaid + was touted to be Tesla’s flagship vehicle, with a range of around 519 miles. After unveiling for the first time last year, American EV maker T...

ByHeart concludes largest U.S. clinical trial for infant food product

ByHeart concludes largest U.S. clinical trial for infant food product

By Nikita Chaurasia

ByHeart Inc., a New-York based infant, and baby nutrition company, has recently announced the completion of the largest clinical trial for new infant formula in the past 25 years. With this move, the company is earmarked to be the 4th FDA registered,...